Company: RVRC
Filing Date: 2025-12-12
Form Type: S-1/A
Source: 0001213900-25-121070
Chunk: 51

Company: Revium Rx.
Filing Date: 2025-12-12
Form: S-1/A
Chunk 51
---
 could cause the price of our Common Stock to fall and the issuance and sale of Common Stock upon exercise of warrants by Selling Stockholders will cause dilution. The issuance of our Common Stock by the Company in the Primary Offering and upon exercise of our outstanding warrants in this Offering will cause immediate and substantial dilution.

Sales of a substantial
number of shares of our Common Stock by Selling Stockholders in the public market, or the perception that these sales might occur, could
depress the market price of our Common Stock and could impair our ability to raise capital through the sale of additional equity securities.
We are unable to predict the effect that sales may have on the prevailing market price of our Common Stock. In addition, the issuance
of shares of our Common Stock in the Primary Offering and upon exercise of the IPO Warrants and the Investor Warrants by the Selling
Stockholders will result in immediate and substantial dilution to the interests of other existing stockholders since the holders of the
warrants may ultimately receive and sell the full number of shares issuable in connection with exercise of such warrants. If the holders
of the warrants choose to do this, it will cause substantial dilution for the holders of our Common Stock.

Article VIII of our Bylaws designates the appropriate state or federal court in Nevada as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by our shareholders, and therefore may limit our shareholders’ ability to choose a forum for disputes with us or our directors, officers, employees, or agents.

Article VIII of our
Bylaws provide that, to the fullest extent permitted by law, and unless we consent to the selection of an alternative forum, the State
or federal court in Nevada shall be the sole and exclusive forum for (a) any derivative action or proceeding brought on behalf of the
Company, (b) any action or proceeding asserting a claim of breach of a fiduciary duty owed by any director or officer of the Company
to the Company or the Company’s shareholders, (c) any action or proceeding asserting a claim against the Company arising pursuant
to any provision of the Nevada Revised Statutes or the Company’s amended and restated articles of incorporation or Second Amended
and Restated Bylaws (as either might be amended from time to time), or (d) any action or proceeding asserting a claim against the Company
governed by the internal affairs doctrine. This exclusive forum provision is not be applicable to any action brought under the Securities
Act of 1933, as